SEC Form D · Amendment · filed August 20, 2021
AmbAgon Therapeutics Inc
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Joseph King · Chicago, ILDirectorKendall J. Saville · Dallas, TXExecBryan Miller · San Francisco, CAExecJ. D. Plants · San Francisco, CAExecJ. E. Virtue · New York, NYDirectorDavid Festi · Washington, PADirectorRichard Wahlstedt · Chicago, ILDirectorRobert Kornblum · Pittsburgh, PAExecRoel Bulthuis · San Francisco, CADirectorMichael R. Wittmeyer · Dallas, TXExecLawrence J. Konis · Santa Monica, CAExecMark D. Allsteadt · NORWALK, CTDirectorNancy Pryer · San Francisco, CAExecJoshua Merrill · San Francisco, CAExecAdam Rosenberg · San Francisco, CADirectorEdward Engler · Pittsburgh, PAExecMichelle Arkin · San Francisco, CADirectorMamoon Hamid · San Francisco, CADirectorHarpoon Ventures Iv GP, LLC · CORONADO, CAExec · DirectorAndreas P. Emmanuel · Dallas, TXExec · DirectorJosh Seidenfeld · San Francisco, CAExecPeter Dudek · San Francisco, CADirectorKenneth Martin · Pittsburgh, PAExecYaniv Tepper · Los Angeles, CADirectorJanwillem Naesens · San Francisco, CADirectorDonald R. Young · Northborough, MADirectorScott Clarke · San Francisco, CAExec · DirectorCraig Kautsch · Fort Worth, TXDirectorAndrew E. Spring · New York, NYDirectorSteven R. Mitchell · Northborough, MADirectorMargarita Chavez · San Francisco, CADirectorAjay Gupta · CHRISTCHURCH, Q2DirectorChristian Ottmann · San Francisco, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗